Pediatrics

Speaking of Urology: Dr. Finkelstein discusses telemedicine for pediatric post-op visits

September 08, 2020

In this episode, Julia Beth Finkelstein, MD, MPH, CPPS, discusses what she and her co-authors learned from a recent study evaluating the use of telemedicine for pediatric post-op visits.

Medical professionals to discuss circumcision on Twitter

October 29, 2012

Join Urology Times and Contemporary Pediatrics for a discussion about controversies over circumcision and its implications.

Pediatric urologists top list of those with long wait times

August 01, 2012

A new national survey shows severe physician shortages among certain pediatric specialties, and pediatric urologists top the list of those registering long wait times for pediatric surgical care.

Pediatric urolithiasis, vesicoureteral reflux evaluation under close scrutiny

May 15, 2012

Stone disease and minimally invasive treatment approaches are once again leading issues in the pediatric urology section of the 2012 AUA annual meeting.

Pediatric stone disease on the rise, but reasons unclear

March 01, 2012

New data showing an increasing incidence of pediatric stone disease is stimulating more research to further describe and understand this troubling phenomenon.

Pediatricians delaying referral of vesicoureteral reflux patients

March 01, 2012

Results of a survey of pediatricians' practice patterns for children with vesicoureteral reflux (VUR) are worrisome in showing these primary care practitioners are retaining their patients longer before referring them to a specialist.

Relatives of vesicoureteral reflux patients at risk for related morbidity

March 01, 2012

Radiologically proven VUR was present in 11 mothers and seven fathers as well as in 36 second-degree relatives (aunts, uncles, grandparents) and 73 third-degree relatives (65 first cousins and eight great-aunts, -uncles or -grandparents) of 259 VUR patients in an Irish study.

Vesicoureteral reflux in young patients: Early detection, treatment key

March 01, 2012

Results of a retrospective study investigating risk factors for the development of renal parenchymal damage in young children with primary high-grade vesicoureteral reflux (VUR) underscore the importance of early detection and treatment to prevent renal damage or its progression from ongoing VUR.

Use of dextranomer/hyaluronic acid copolymer (Deflux) for vesicoureteral reflux rising; long-term results vary

March 01, 2012

Use of Dx/HA (Deflux) for the treatment of vesicoureteral reflux (VUR) in children increased rapidly after it gained FDA approval. Despite high rates of utilization and positive early findings, more recent reports are raising questions about long-term outcomes and prompting further research.

Post-treatment downgrading of vesicoureteral reflux beneficial in high-grade cases

March 01, 2012

Downgrading of high-grade vesicoureteral reflux (VUR) after endoscopic treatment performed because of breakthrough urinary tract infections results in cessation of febrile UTIs and, often, spontaneous VUR resolution as well.